Si H, Lu H, Yang X, Mattox A, Jang M, Bian Y, Sano E, Viadiu H, Yan B, Yau C, Ng S, Lee S K, Romano R-A, Davis S, Walker R L, Xiao W, Sun H, Wei L, Sinha S, Benz C C, Stuart J M, Meltzer P S, Van Waes C, Chen Z
Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, Maryland, USA.
Orthopaedic Center, Zhujiang Hospital Guangzhou, Guangdong, China.
Oncogene. 2016 Nov 3;35(44):5781-5794. doi: 10.1038/onc.2016.112. Epub 2016 May 2.
The Cancer Genome Atlas (TCGA) network study of 12 cancer types (PanCancer 12) revealed frequent mutation of TP53, and amplification and expression of related TP63 isoform ΔNp63 in squamous cancers. Further, aberrant expression of inflammatory genes and TP53/p63/p73 targets were detected in the PanCancer 12 project, reminiscent of gene programs comodulated by cREL/ΔNp63/TAp73 transcription factors we uncovered in head and neck squamous cell carcinomas (HNSCCs). However, how inflammatory gene signatures and cREL/p63/p73 targets are comodulated genome wide is unclear. Here, we examined how the inflammatory factor tumor necrosis factor-α (TNF-α) broadly modulates redistribution of cREL with ΔNp63α/TAp73 complexes and signatures genome wide in the HNSCC model UM-SCC46 using chromatin immunoprecipitation sequencing (ChIP-seq). TNF-α enhanced genome-wide co-occupancy of cREL with ΔNp63α on TP53/p63 sites, while unexpectedly promoting redistribution of TAp73 from TP53 to activator protein-1 (AP-1) sites. cREL, ΔNp63α and TAp73 binding and oligomerization on NF-κB-, TP53- or AP-1-specific sequences were independently validated by ChIP-qPCR (quantitative PCR), oligonucleotide-binding assays and analytical ultracentrifugation. Function of the binding activity was confirmed using TP53-, AP-1- and NF-κB-specific REs or p21, SERPINE1 and IL-6 promoter luciferase reporter activities. Concurrently, TNF-α regulated a broad gene network with cobinding activities for cREL, ΔNp63α and TAp73 observed upon array profiling and reverse transcription-PCR. Overlapping target gene signatures were observed in squamous cancer subsets and in inflamed skin of transgenic mice overexpressing ΔNp63α. Furthermore, multiple target genes identified in this study were linked to TP63 and TP73 activity and increased gene expression in large squamous cancer samples from PanCancer 12 TCGA by CircleMap. PARADIGM inferred pathway analysis revealed the network connection of TP63 and NF-κB complexes through an AP-1 hub, further supporting our findings. Thus, inflammatory cytokine TNF-α mediates genome-wide redistribution of the cREL/p63/p73, and AP-1 interactome, to diminish TAp73 tumor suppressor function and reciprocally activate NF-κB and AP-1 gene programs implicated in malignancy.
癌症基因组图谱(TCGA)网络对12种癌症类型(泛癌12)的研究揭示了TP53的频繁突变,以及鳞状细胞癌中相关TP63异构体ΔNp63的扩增和表达。此外,在泛癌12项目中检测到炎症基因以及TP53/p63/p73靶点的异常表达,这让人联想到我们在头颈部鳞状细胞癌(HNSCC)中发现的由cREL/ΔNp63/TAp73转录因子共同调节的基因程序。然而,炎症基因特征和cREL/p63/p73靶点在全基因组范围内是如何共同调节的尚不清楚。在这里,我们使用染色质免疫沉淀测序(ChIP-seq)研究了炎症因子肿瘤坏死因子-α(TNF-α)如何在HNSCC模型UM-SCC46中广泛调节cREL与ΔNp63α/TAp73复合物的重新分布以及全基因组特征。TNF-α增强了cREL与ΔNp63α在TP53/p63位点上的全基因组共占据率,同时意外地促进了TAp73从TP53位点向激活蛋白-1(AP-1)位点的重新分布。通过ChIP-qPCR(定量PCR)、寡核苷酸结合试验和分析超速离心独立验证了cREL、ΔNp63α和TAp73在NF-κB、TP53或AP-特异性序列上的结合和寡聚化。使用TP53、AP-1和NF-κB特异性反应元件或p21、SERPINE1和IL-6启动子荧光素酶报告基因活性证实了结合活性的功能。同时,TNF-α调节了一个广泛的基因网络,在阵列分析和逆转录PCR中观察到cREL、ΔNp63α和TAp73具有共结合活性。在鳞状癌亚组和过表达ΔNp63α的转基因小鼠的炎症皮肤中观察到重叠的靶基因特征。此外,本研究中鉴定的多个靶基因与TP63和TP73活性相关,并通过CircleMap在泛癌12 TCGA的大鳞状癌样本中增加了基因表达。PARADIGM推断通路分析揭示了TP63和NF-κB复合物通过AP-1枢纽的网络连接,进一步支持了我们的发现。因此,炎症细胞因子TNF-α介导cREL/p63/p73和AP-1相互作用组在全基因组范围内的重新分布,以削弱TAp73的肿瘤抑制功能,并相互激活与恶性肿瘤相关的NF-κB和AP-1基因程序。